Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank57
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P57
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | -11.94% |
| 2023 | -22.41% |
| 2022 | -63.07% |
| 2021 | 1520.43% |
| 2020 | -83.34% |
| 2019 | 0.00% |
| 2018 | -100.00% |
| 2017 | 0.00% |